Eledon Pharmaceuticals In...

NASDAQ: ELDN · Real-Time Price · USD
2.60
0.00 (0.00%)
At close: Aug 15, 2025, 12:45 PM

Eledon Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a 373K 195K
Gross Profit
n/a -374K -373K -195K
Operating Income
-70.58M -43M 8.49M -36.87M
Interest Income
n/a n/a n/a n/a
Pretax Income
-35.75M -40.33M -87.97M -36.86M
Net Income
-35.32M -40.33M -87.5M -34.51M
Selling & General & Admin
18.61M 12.69M 12.7M 13.13M
Research & Development
51.96M 30.31M 27.08M 23.73M
Other Expenses
n/a n/a n/a 7K
Operating Expenses
70.58M 43M 39.78M 36.87M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-70.58M 43.4M 39.78M 36.87M
Income Tax Expense
431K n/a -462K -2.35M
Shares Outstanding (Basic)
48.54M 24.62M 14.29M 14.82M
Shares Outstanding (Diluted)
48.54M 24.62M 14.29M 14.82M
EPS (Basic)
-0.73 -0.00 -6.13 -2.33
EPS (Diluted)
-0.07 -1.64 -6.13 -2.33
EBITDA
-35.39M -116.16M -87.59M -36.66M
EBIT
-35.75M -43M -87.97M -36.86M
Depreciation & Amortization
359K 374K 373K 195K